Index Identifies Subclinical Heart Failure Risk in Type 2 Diabetes
The triglyceride-glucose index correlated with subclinical heart failure with preserved ejection fraction in asymptomatic patients with type 2 diabetes.
Stay updated with breaking news from Ipid Management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The triglyceride-glucose index correlated with subclinical heart failure with preserved ejection fraction in asymptomatic patients with type 2 diabetes.
A “smart blood” platform delivered antibiotics to E coli without harming normal cells.
The small interfering RNA product showed reductions of more than 95% in levels of Lp(a) at doses of 75 mg or more when given every 12 weeks in a new phase 2 study.
In the phase 3 PROMINENT trial, pemafibrate improved multiple lipid fractions in patients with type 2 diabetes, without any impact on cardiovascular events.
Although the open-label trial has many limitations, it could add some support to findings from the REDUCE-IT study, which showed a reduction in cardiovascular events with high-dose eicosapentaenoic acid.